Chebib FT, Zhou X, Garbinsky D, Davenport E, Nunna S, Oberdhan D, Fernandes A. Tolvaptan and kidney function decline in older individuals with autosomal dominant polycystic kidney disease: a pooled analysis of randomized clinical trials and observational studies. Kidney Med. 2023 Jun;5(6):100639. doi: 10.1016/j.xkme.2023.100639
Le Moine JG, Fiestas Navarrete L, Katumba K, Launois R. Psychometric validation of the 14 items chronic venous insufficiency quality of life questionnaire (CIVIQ-14): confirmatory factor analysis. Eur J Vasc Endovasc Surg. 2016 Feb;51(2):268-74. doi: 10.1016/j.ejvs.2015.08.020.
Carroll I, Thomas JB, Dykstra LA, Granger AL, Allen RM, Howard JL, Pollard GT, Aceto MD, Harris LS. Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist. Eur J Pharmacol. 2004 Oct 6;501(1-3):111-9.
Pladevall M, Arana A, Varas-Lorenzo C. Systematic reviews and meta-analyses in ischemic cardiopathy. Cardiovasc Risk Fact. 2000;4:270-81.
Pladevall-Vila M, Arana A, Varas-Lorenzo C. Systematic reviews and meta-analysis on coronary heart disease. (Revisiones sistemáticas y meta-análisis en cardiopatía isquemica). Cardiovasc Risk Fact. 2000;4:270-81.